Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2005
11/03/2005US20050245445 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
11/03/2005US20050244844 serine/threonine phosphatases (PP1); immobilization, screening
11/03/2005US20050244840 Method of screening anti-mycobacterial molecules
11/03/2005US20050244823 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
11/03/2005US20050244421 Compositions and methods for modulating immune response
11/03/2005CA2564453A1 Peptide inhibitors of metalloproteinase activity
11/03/2005CA2563463A1 Convergent synthesis for kahalalide compounds
11/03/2005CA2551643A1 Metal-containing nanolayered composites, and applications thereof
11/02/2005EP1591453A1 Modified peptides yy and conjugates thereof
11/02/2005EP1591450A1 Conjugate for retention in blood and cancer tissue-specific drug delivery
11/02/2005EP1591160A2 Releasable polymer arrays
11/02/2005EP1590458A2 Bradykinin b2 receptor antagonist peptide from amphibian skin
11/02/2005EP1590366A1 Peptidic sulfonamides
11/02/2005EP1590363A2 Bh3 peptides and method of use thereof
11/02/2005EP1268524B1 Binding peptides for carcinoembryonic antigen (cea)
11/02/2005EP1242363B1 Cd45 inhibitors
11/02/2005EP0793675B1 Hiv-1- and hiv-2-peptides for inhibition of membrane fusion-associated events, including hiv transmission
11/02/2005CN1691964A Epitope sequences
11/02/2005CN1225474C 肽载体 Peptide carrier
11/02/2005CN1225473C Method of preparing cyclic vasoactive peptides
11/01/2005US6960648 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents
11/01/2005US6960646 Cyclic peptides as potent and selective melanocortin-4 receptors agonists
10/2005
10/27/2005WO2005100382A1 Vertebrate peptide modulators of lipid metabolism
10/27/2005WO2005100381A2 Processes for preparing eptifibatide and pertinent intermediate compounds
10/27/2005WO2005099742A1 Vascular network forming agent
10/27/2005WO2005099741A1 Remedy for motoneuron diseases
10/27/2005WO2005037854A3 Immunogenic peptides
10/27/2005WO2005033311A3 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis
10/27/2005WO2005000870A3 Isolated ny-eso-1 peptides which bind to hla class ii molecules and uses thereof
10/27/2005WO2004081030A8 Peptides selectively lethal to malignant and transformed mammalian cells
10/27/2005WO2003106643A3 Novel polynucleotides encoding lamprey gnrh-iii
10/27/2005WO2002057313A8 Receptor-binding compounds and methods for identifying them
10/27/2005US20050240012 Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity
10/27/2005US20050239870 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; aminoalkylamide, piperidine-, indole-, or pyrrole-amide derivatives; anticarcinogenic agents
10/27/2005US20050239711 Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
10/27/2005US20050239709 Synthetic antimicrobial polypeptides
10/27/2005US20050239701 Transient and/or permanent modification of sexual behavior and/or fertility using recombinant chimeric GnRH
10/27/2005US20050239693 Template-fixed peptidomimetics with antibacterial activity
10/27/2005US20050239691 Cross-linked glycopeptide - cephalosporin antibiotics
10/27/2005US20050239690 Intermediate for preparing glycopeptide derivatives
10/27/2005US20050239684 Compounds which inhibit beta-secretase activity and methods of use thereof
10/27/2005US20050239204 Multifunctional molecular complexes for gene transfer to cells
10/27/2005US20050238642 Modified bouganin proteins, cytotoxins and methods and uses thereof
10/27/2005US20050238615 Process for the production of dendritic trimesic acid triamides
10/27/2005US20050238607 FGF-5 supported and binding peptides
10/26/2005EP1589108A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
10/26/2005EP1589107A1 Immunoglobulins devoid of light chains
10/26/2005EP1588761A2 Combinatorial strategies for polymer synthesis
10/26/2005EP1587944A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
10/26/2005EP1587907A2 Kunitz domain library
10/26/2005EP1587819A2 Isolation and purification procedure of vasopeptidase peptide inhibitors
10/26/2005EP1576126A3 Systems for capture and analysis of biological particles and methods using the systems
10/26/2005EP1246837B1 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides
10/26/2005CN1688600A Template-fixed peptidomimetics with antibacterial activity
10/26/2005CN1688599A Use of dipeptidyl peptidase IV inhibitor
10/26/2005CN1688338A Method of humanizing immune system molecules
10/26/2005CN1687118A Cyclic peptide containing arginine, glycine, asparagicacid-sequence and active target liposome
10/26/2005CN1687117A Active polypeptide possessing action for promoting mitosis of horny cell and its application
10/26/2005CN1687116A Antigen epitope II of neutrality B cell of chicken IBDV VP2 protein and application thereof
10/26/2005CN1687115A Agglutinin protein of astragalus root and preparation method thereof
10/26/2005CN1687114A Method for purifying microcysin LR and RR synchronously
10/26/2005CN1687113A Antigen epitope I of B cell of chicken IBDV VP3 protein
10/26/2005CN1687112A Antigen epitope I of neutrality B cell of chicken IBDV VP2 protein
10/26/2005CN1687111A Antigen epitope II of B cell of chicken IBDV VP3 protein
10/26/2005CN1687110A Method for separating lacti-streptocin from fermentation liquid of lacti-galactococcus
10/26/2005CN1224630C Targetted polypeptide for specificity of liver cancer blood vessel
10/26/2005CN1224419C Orally administered peptides to ameliorate a therosclerosis
10/25/2005US6958383 Streptogramin derivatives, preparation method and compositions containing same
10/25/2005US6958319 Stability and longer shelf life; bortezomib N-(2-pyrazine)carbonyl-L-phenylalanine-L-leucine boronic acid
10/25/2005US6958240 Inhibition of major groove DNA binding proteins by modified polyamides
10/25/2005US6958151 Miniprotein ligands and other polypeptides and methods for making and using same
10/20/2005WO2005098435A2 Peptides and peptidomimetics binding to cd23
10/20/2005WO2005097828A2 Peptides of cav2.2 that inhibit pain
10/20/2005WO2005097822A1 Identification of the precise amino acid sequence of the epitope recognized by the potent neutralizing human anti-hiv-1 monoclonal antibody igg1b12
10/20/2005WO2005097820A1 Peptides for inhibiting mdm2 function
10/20/2005WO2005097156A1 Remedy for neurodegenerative diseases
10/20/2005WO2005035525A3 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease
10/20/2005WO2005016260A3 Prodrugs for the oral and parenteral delivery of amine-containing drugs, amino acids, and peptides
10/20/2005WO2005016244A3 Methods and compositions for the treatment of gastrointestinal disorders
10/20/2005WO2005007198A3 Design of disease specific agents for diagnostics and therapeutics based on the protein isoform of vegf, her-2, psa
10/20/2005WO2005000876A3 Ring finger family proteins and uses related thereto
10/20/2005WO2004103266A8 Protein kinase c peptides for use in withdrawal
10/20/2005WO2004090103A3 Identification of novel nogo-receptors and methods related thereto
10/20/2005US20050233972 Neuropeptides and their use for pest control
10/20/2005US20050233971 A hexapeptide contains 4-hydroxyphenylglycine, threonine and phenylalanine units with branched amino groups; cyclic peptides; infection is caused by Bacillus, Clostridium, Staphylococcus, Streptococcus, Enterococcus, Mycobacterium; binds to a structural motif of a pyrophosphates
10/20/2005US20050233952 Peptide structure containing lanthionine and methyllanthionine as constituents isolated from Microbispora sp. ATCC PTA-5024; methicillin resistant and vancomycin resistant bacteria; M. catharralis, Neisseria species and H. influenzae and Mycobacteria
10/20/2005US20050233951 Novel two gonadotropin releasing hormones and a method to isolate the same
10/20/2005US20050233943 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
10/20/2005US20050233413 Neuroprotective polypeptides and methods of use
10/20/2005US20050233387 Assay method
10/20/2005US20050233350 Method for typing of minor histocompatibility antigen HA-1
10/20/2005CA2563513A1 Remedy for neurodegenerative diseases
10/20/2005CA2562385A1 Identification of the precise amino acid sequence of the epitope recognized by the potent neutralizing human anti-hiv-1 monoclonal antibody igg1b12
10/20/2005CA2560726A1 Peptides and peptidomimetics binding to cd23
10/19/2005EP1586641A2 Compounds for the treatment of hypercalcemia and hypocalcemia
10/19/2005EP1586586A2 Peptide and/or proteins and their use for the manufacture of a therapeutic and/or preventive medicament
10/19/2005EP1586584A1 Modulators of beta-amyloid peptide aggregation comprising D-amino acids
10/19/2005EP1586581A2 Non-Mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
10/19/2005EP1586580A2 Process for the purification of daptomycin
10/19/2005EP1586324A1 Ophthalmic therapeutic composition
1 ... 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 ... 423